INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC

Group 1 - Monteverde & Associates PC is investigating GlycoMimetics, Inc. regarding a proposed merger with First Crescent Biopharma, Inc. [1] - Under the merger agreement, pre-acquisition GlycoMimetics stockholders are expected to own approximately 3.1% of the combined company, while pre-acquisition Crescent stockholders are expected to own approximately 96.9% [1] Group 2 - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report and has a successful track record in recovering money for shareholders [1][2] - The firm operates from the Empire State Building in New York City and specializes in class action securities litigation [2]